You just read:

Genomic Health Announces Positive Topline Clinical Validation Study Results Demonstrating Oncotype DX® Prostate Cancer Test Predicts Risk of Metastasis and Mortality

News provided by

Genomic Health, Inc.

Nov 01, 2016, 16:04 ET